Novel approaches to treating advanced systemic mastocytosis | CPAA
Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression - Verstovsek - 2013 - European Journal of Haematology - Wiley Online Library
KIT and Other Mutations in Mastocytosis | SpringerLink
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications | Modern Pathology
c-Kit (D816V) Protein, active, 10 µg | 14-611
KIT D816V ddPCR | ARUP Laboratory
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis | Leukemia
Mutation D816V Alters the Internal Structure and Dynamics of c-KIT Receptor Cytoplasmic Region: Implications for Dimerization and Activation Mechanisms | PLOS Computational Biology
American Journal of Hematology | Blood Research Journal | Wiley Online Library
Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasms: Molecular Therapy
PPT - c-kit and the D816V Mutation PowerPoint Presentation, free download - ID:4996307
Detection of the c-kit D816V mutation in systemic mastocytosis by allele-specific PCR | Journal of Clinical Pathology
Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations - ScienceDirect
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis - eBioMedicine
IJMS | Free Full-Text | Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis
Molecular defects in mastocytosis: KIT and beyond KIT. | Semantic Scholar
Frontiers | Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
The D816V mutation in the catalytic domain of the c-Kit receptor... | Download Scientific Diagram
Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis | Modern Pathology
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis - eBioMedicine
JQ on X: "$BPMC BLU-285 and $NVS Midostaurin (77/89 patients with KIT D816V mutation) in advanced systemic mastocytosis https://t.co/DIwP6XKR8n https://t.co/drIpwNGjhX" / X
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis | Leukemia
Bidirectional sequencing of KIT exon 17 demonstrated a D816V mutation... | Download Scientific Diagram
.JPG-650.jpg "Eurofins DiscoverX c-Kit (D816V) Protein, Active Quantity: 250 μg Eurofins DiscoverX c-Kit (D816V) Protein, Active | Fisher Scientific")
Eurofins DiscoverX c-Kit (D816V) Protein, Active Quantity: 250 μg Eurofins DiscoverX c-Kit (D816V) Protein, Active | Fisher Scientific
Frontiers | CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis
